TP53 and pancreatic neoplasm: Vandetanib also demonstrated a direct connection between the outcomes of molecular mechanics and the prognosis of particular proteins in pancreatic tumors when multiomics, molecular dynamics, and system biology analyses of KRAS and TP53 mutations in PDAC were conducted.